Photo via Global News

GLP-1 pill vs injection: How do they compare for Canadians?

Read the original at Global News ↗
Cite

Rana, U. (2026, November 19). GLP-1 pill vs injection: How do they compare for Canadians? Global News. https://globalnews.ca/news/12158434/glp1-pill-vs-injection/

Dated from the outlet's own feed. Check the original for its byline.

Global News · collected 2026-11-19 · by Uday Rana

Quick Summary

Health Canada has approved Eli Lilly’s once-daily oral GLP-1 pill, Foundayo, for weight loss and Type 2 diabetes management in adults. The pill joins other GLP-1 medications like Zepbound and Mounjaro, which require weekly injections. Foundayo, containing orforglipron, is expected to be available in Canadian pharmacies in January. Dr. Hertzel Gerstein emphasizes that patient preference often dictates the choice between pills and injections, with some preferring the convenience of weekly shots and others opting for daily pills.
Written by AI on 2026-11-22, from this article's own text only (the story summary below draws on all the coverage).

Compared with similar articles

This article reads unscored and hedges 14% of its claims. Each row says how that neighbour differs.
The Sydney Morning Herald
Hedges 2 of 17 claims Outlet record 61/100
“The articles describe the approval and availability of GLP-1 pills in different countries (Canada and Australia) and at different times, indicating different specific events.”

Story

GLP-1 Pill Vs Injection Comparison
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
59
sentences that state something as happening or true
Uncertain
14%
8 of 59 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
63/100
Global News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-22 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Global News · 3576 article(s) · 13 correction(s) detected
Running correction rate · 13 correction(s)

Who wrote this

Uday Rana
51 article(s) here · 1 carrying a prediction
“Hopefully, we can choose from the best features available to create a really beautiful new facility that students and staff will feel both safe and comfortable in for the long term in Tumbler Ridge,” Anderson said.
“The leaders discussed the work underway to reach a mutually beneficial trade agreement that would create good jobs, boost affordability, and fully respect Canada’s languages, culture, and sovereignty.
More than a quarter of Canadians, apparently, who would rather open an envelope full of cash instead, a new survey shows.
Industry Minister Melanie Joly and Ontario Premier Doug Ford are set to announce new supports for Canada’s auto manufacturing sector, which is reeling from U.S. President Donald Trump’s tariffs.
There may soon be a second GLP-1 weight-loss pill option in Canada: competitor Novo Nordisk’s Wegovy pill, which is still awaiting Health Canada approval.
In exchange, Ottawa said it would expand what is called remissions coverage to 32 more steel and aluminum items from China.
As Ottawa looks to intensify its trade relationship with Beijing after a meeting between Prime Minister Mark Carney and Chinese President Xi Jinping, Canada’s auto industry is sounding the alarm over the question of whether those talks could open the door to Chinese “knock-down kits” or “kit cars,” warning of their impact on domestic jobs. “We see no evidence in markets around the world that China will do anything but knock-down kits,” said Brian Kingston, president and CEO of the Canadian Vehicle Manufacturers’ Association President.
More details can be found in the Microsoft 365 admin center under EX1550543,” Microsoft said in a statement on X. “While we’re working to mitigate impact, we’ve confirmed the issue may affect Microsoft 365 service connectivity for users in any region, more information will be provided in the Microsoft 365 admin center under EX1550543.
The Canadian economy is forecast to grow at one per cent in 2026, with GDP growth ramping up to 1.8 per cent in 2027 and two per cent in 2028, KPMG’s Fall 2026 Economic Outlook said.
The ceremony will begin with a veterans’ march, followed by the arrival of various dignitaries including the Speakers of the House of Commons and the Senate, the minister of veterans affairs, the chief of the defence staff, the Silver Cross Mother and the governor general, who will receive the vice-regal salute and inspect the assembled troops for the commemoration.
Also by Uday Rana
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 51 articles by Uday Rana →

Topics

Eli Lilly Eli Lilly’s Foundayo Health Canada Wegovy

Subjects

Eli Lilly ORG · 3× Foundayo ORG · 3× Gerstein PERSON · 3× Health Canada ORG · 3× Canada GPE · 2× Eli Lilly’s ORG · 2× Novo Nordisk’s ORG · 2× Canadians NORP · 1× Hertzel Gerstein PERSON · 1× McMaster University ORG · 1×

Narrative

BC Nurses’ Union says arbitration in labour dispute has ended - Saskatchewan recovery centre, accused of falsifying records, to be investigated by auditor - ‘Vanderpump Rules’ star Jax Taylor reveals cancer diagnosis, tumour surgery Convenience is not the only factor for most patients, Gerstein said.
framing: assertive · carried by 1 article(s) · first seen 2026-11-22
There may soon be a second GLP-1 weight-loss pill option in Canada: competitor Novo Nordisk’s Wegovy pill, which is still awaiting Health Canada approval.
2026-11-22 · Global News
GLP-1 pill vs injection: How do they compare for Canadians? · assertive framing

Claims (59 extracted, 8 hedged)

The rapid growth in the GLP-1 medication market got yet another boost this week as Health Canada approved Eli Lilly’s once-a-day oral pill Foundayo for weight loss. asserted
Canada → get → loss
Eli Lilly has already cemented its position as market leader, with sales of its drugs Zepbound and Mounjaro skyrocketing. asserted
sales → cement → drugs
As Foundayo is on the horizon for Canadians, how does the pill compare to injectable GLP-1 drugs? What is Foundayo? asserted
Foundayo → compare → drugs
On Wednesday, Eli Lilly’s Foundayo was approved for adults with obesity as well as those who are overweight and have at least one related medical problem, such as high blood pressure or sleep apnea. asserted
who → approve → pressure
In addition to promoting and maintaining weight loss, the pill is also approved to help treat Type 2 diabetes. asserted
pill → promote → diabetes
The increasing availability of oral GLP-1 medication helps provide more options for patients, said Dr. Hertzel Gerstein, professor of medicine at McMaster University and Hamilton Health Sciences. asserted
Gerstein → increase → University
“Choice is good, and the more options that we have, the more any particular person can find the thing that works for them,” said Gerstein, who is a diabetes researcher and a doctor. asserted
who → have → them
There is another GLP-1 pill — Novo Nordisk’s Rybelsus — already on the market in Canada, but it is only approved for Type 2 diabetes management and not for weight loss. asserted
it → be → loss
Foundayo received Health Canada authorization on Nov. 13. asserted
Foundayo → receive → Nov.
Eli Lilly spokesperson Ethan Pigott said the company expects the pills to be available in pharmacies in January. asserted
pills → say → January
There may soon be a second GLP-1 weight-loss pill option in Canada: competitor Novo Nordisk’s Wegovy pill, which is still awaiting Health Canada approval. uncertain
which → await → approval
Both Foundayo and the Wegovy pill are approved and available in the U.S. How does it work? asserted
it → approve → U.S.
The key difference between the two forms is how frequently you have to take them. asserted
you → have → them
Zepbound, like other major injectables, must be administered weekly, while Foundayo and other oral GLP-1 drugs are a once-a-day pills. asserted
Foundayo → administer → injectables
Whether a doctor prescribes the oral medication or the shot often comes down to what the patient is most likely to follow through on, Gerstein said. asserted
Gerstein → prescribe → what
Get weekly health news “You treat a patient, not a disease,” he said. asserted
he → get → patient
“Some people would prefer the injection once a week and then forget about it. asserted
people → prefer → it
Some people will prefer the pill,” he added. asserted
he → prefer → pill
The Wegovy pill and injection have the same active ingredient – semaglutide. asserted
pill → have → ingredient
This means that for the oral pill, the dosage is typically much larger so that it can be absorbed by the gut. asserted
it → mean → gut
While the Wegovy injection comes in doses ranging from an initial dose of 0.25 milligrams weekly to 2.4 milligrams, the daily oral pill can range from 1.5 milligrams for the first 30 days and ramp up to a maximum dosage of 1.5 milligrams. “You can think about it as a cover on the drug. asserted
You → come → drug
When you take it by mouth, that cover dissolves, but the drug never gets broken up,” said Jennifer Lake, a pharmacist and assistant professor at Leslie Dan Faculty of Pharmacy at the University of Toronto. asserted
Lake → take → Toronto
On the other hand, the Eli Lilly pill uses a different active ingredient than its injectable drugs. asserted
pill → use → drugs
While the Zepbound injection uses tirzepatide, a GLP-1 receptor, Foundayo uses orforglipron. asserted
Foundayo → use → orforglipron
“It’s not a protein, this drug orforglipron. asserted
It → ’ → ?
It’s actually a large molecule which mimics a protein effect but is absorbed through the gut a lot easier,” Gerstein said. asserted
Gerstein → ’ → gut
An initial dose of the Zepbound injection is 2.5 milligrams, ramping up to a maximum dose of 15 milligrams. asserted
dose → ramp → milligrams
On the other hand, an initial dose of the Foundayo pill is 0.8 milligrams and can only go as high as 17.2 milligrams. asserted
dose → go → milligrams
One key difference between both oral pills is that a semaglutide-based pill must be had on an empty stomach, according to the Yale Medicine website. uncertain
pill → base → website
“Food triggers the release of stomach acids and digestive enzymes that can break the drug down before absorption occurs,” the website says. asserted
website → trigger → drug
Foundayo, on the other hand, is taken once a day at any time, with or without food, the website added. asserted
website → take → food
“It doesn’t matter if you take it with food or not. asserted
you → matter → food
This really is a big flexibility for how people normally take medications once a day when it fits in their schedule,” Lake said. asserted
Lake → take → schedule
- New Brunswick adopts HPV testing for cervical cancer, Nova Scotia urged to follow - asserted
Scotia → adopt → cancer
BC Nurses’ Union says arbitration in labour dispute has ended - Saskatchewan recovery centre, accused of falsifying records, to be investigated by auditor - ‘Vanderpump Rules’ star Jax Taylor reveals cancer diagnosis, tumour surgery Convenience is not the only factor for most patients, Gerstein said. asserted
Gerstein → say → patients
“Obviously, for a patient, there are issues of what their drug plan will cover,” he said. asserted
he → be → what
For patients without insurance, Zepbound can cost between $275 and $650 per month in Canada, according to Canadian digital health platform Felix. uncertain
Zepbound → cost → Felix
The Wegovy injection can cost between $400 and $570, while a 30-day Rybelsus refill can cost just over $300. asserted
refill → cost → 300
In the U.S., the Wegovy pill can cost between US$149 and US$299 per month without a commercial insurance plan, while Foundayo has a list price of US$650 for a 30-day supply without an insurance plan. asserted
Foundayo → cost → plan
This year, Canada became the first G7 country to approve generic semaglutide. asserted
Canada → become → semaglutide
…and 19 more, not listed.
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support